Our goal was to investigate the clinical significance of IGF2BP3 (mRNA and protein) in melanoma progression and evaluate which quantification method, RT-qPCR or IHC, provides a higher prognostic value of the expression of IGF2BP3 among primary melanomas. Here, IGF2BP3 is linked to melanoma.